Abstract
Diabetic nephropathy is the leading cause of end‐stage renal disease and characterized by excessive accumulation of extracellular matrix (ECM) in the kidney. The role of epithelial‐mesenchymal transition (EMT) in the development of renal fibrosis is well known. Histone deacetylase (HDAC) inhibitors have been shown to exert antifibrotic effect but the role of HDAC in diabetic renal injury remains incompletely understood. Here we demonstrate that trichostatin A (TSA), a nonselective HDAC inhibitor, prevents albuminuria, EMT, and enhanced ECM expression in streptozotocin‐induced diabetic rat kidney without significant effect on blood glucose. Hyperacetylation of histone (H3 and H4) by TSA is associated with downregulation of ECM mRNAs and reversal of EMT in TGF‐β1‐stimulated normal rat kidney tubular epithelial (NRK52E) cells. TGF‐β1 significantly increases activity of HDAC 2, a class I HDAC, and HDAC 2 silencing using small interference RNA represses TGF‐β1‐induced ECM upregulation and EMT in NRK‐52E cells. These results support an important role for HDAC 2 in the development and progression of renal fibrosis and suggest HDAC 2 as a novel therapeutic target for the attenuation of diabetic renal injury. (Supported by R01‐2006‐000‐10829‐0s and R15‐2006‐020 from KOSEF and BK 21)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.